Several favorable effects of SGLT2 inhibitors such as increased diuresis [24], decreased arterial stiffness [25], weight and blood pressure reduction [1,26], and other cardiac benefits [27] contribute to positive outcomes in heart failure. Here, SLC5A2 is linked to heart failure.